-
1321
Situational analysis on porcine diseases: general risk assessment and prioritization of epizootic threats to biosecurity systems of pig establishments in the Russian Federation
Published 2024-09-01“…The specific features of epizootiology of the agents of African swine fever, classical swine fever, porcine reproductive and respiratory syndrome that can impact the effectiveness of biosecurity systems of pig establishments, as well as further ways for improving biosecurity management measures are discussed. …”
Get full text
Article -
1322
Activities of Some Medicinal Plants on the Proliferation and Invasion of Brain Tumor Cell Lines
Published 2020-01-01“…In this work, five medicinal plants used by TMPs in Borno State, Nigeria, were tested against two brain tumor cell lines. …”
Get full text
Article -
1323
-
1324
-
1325
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
Published 2025-02-01“…A major obstacle in treating these conditions is the blood-brain barrier (BBB), which restricts the passage of therapeutic agents to the brain. Nanotechnology, particularly the use of nanoparticles (NPs), offers a promising solution to this challenge. …”
Get full text
Article -
1326
-
1327
Biofilm as a supracellular organization of pathogenic bacteria
Published 2024-12-01Get full text
Article -
1328
Modern possibilities of tear film stability restoration
Published 2024-09-01“…One of the ways to increase the viscosity, ocular surface stability and humectant duration is the cross-linking of hyaluronic acid using so-called "cross-linking agents" (carbodiimide hydrochloride, urea, divinyl sulfone, thiol-ene reaction, etc.). …”
Get full text
Article -
1329
Comparative analysis of the efficacy and safety of fixed-dose combinations versus their individual components for open-angle glaucoma
Published 2019-04-01“…Seleznev<sup>1</sup><br> <sup>1</sup>Ivanovo State Medical Academy, Ivanovo, Russian Federation<br> <sup>2</sup> Central Military Clinical Hospital named after P.V. …”
Get full text
Article -
1330
Marine natural products as a source of novel anticancer drugs: an updated review (2019–2023)
Published 2025-01-01Get full text
Article -
1331
Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
Published 2023-06-01Get full text
Article -
1332
-
1333
Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
Published 2025-01-01Get full text
Article -
1334
Exploring the Potential of SGLT-2 Inhibitors in Cancer Treatment: Mechanisms, Preclinical Findings, and Clinical Implications
Published 2025-01-01“…By understanding the potential of these agents to alter tumor metabolism and the immune microenvironment, we can evaluate their therapeutic value in cancer management. …”
Get full text
Article -
1335
-
1336
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Published 2013-01-01Get full text
Article -
1337
EXPERIENCE IN PRESERVING THE GENETIC DIVERSITY OF STONE FRUITS USING THE BORDER HEDGING TECHNOLOGY
Published 2019-10-01“…This method makes it quite economical (in terms of space reduction, simplification of the system of care for the storage garden, and decreasing the use of chemical protection agents) to maintain a large number of live accessions ex situ. …”
Get full text
Article -
1338
Anti-VEGF therapy for proliferative diabetic retinopathy: translating research evidence into clinical practice
Published 2020-06-01“… Kuskov<sup>2</sup></b> </p> <p> <b><sup>1</sup></b><b>Kazan State Medical Academy — Branch of the Russian Medical Academy of Continuous </b><b>Professional Education, Kazan, Russian Federation</b> </p> <p> <b><sup>2</sup>Prof. …”
Get full text
Article -
1339
Venous thromboembolic events: case history
Published 2019-11-01“…Complex treatment for venous thromboembolism and central retinal thrombosis (involving neuroprotective agents) should be applied.</i> </p> <p> <i><b>Keywords</b>: hereditary thrombophilia, thromboembolism, pulmonary embolism, PE, retinal vein occlusion, hemostatic system.…”
Get full text
Article -
1340
Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia
Published 2006-01-01“…Fetal hemoglobin switching agents have been proposed to treat genetic blood disorders, such as sickle cell anemia and beta-thalassemia, in an effort to compensate for the dysfunctional form of the beta-globin chain in adult hemoglobin. …”
Get full text
Article